The review process at the FDA is driving investment in medical technologies overseas as well as sending jobs overseas.
Tim Murphy: “The review process at the FDA is driving investment in medical technologies overseas as well as sending jobs overseas.”
Editor's note · Context
Tim Murphy highlights the negative impact of FDA processes on U.S. medical technology investment.
Share
More from Tim Murphy
I just want to say, investing in the AOT program, Congress says it is worth it to ensure the most vulnerable among us have the treatment they need, instead of being in ERs, or jails. This pilot is extremely important. It saves money. It…
Acting on these recommendations would improve EPA's ability to carry out its core mission, protecting human health and the environment.
It’s maybe the single most toxic issue in the midterms this side of, you know, gas prices.
I demand a recorded vote. The Acting CHAIR. Pursuant to clause 6 of rule XVIII, further proceedings on the amendment offered by the gentleman from Pennsylvania will be postponed. Amendment No. 156 Offered by Mr. Kelly of Pennsylvania The…





